Kumar is the Chief Technology Officer at ACTO. ACTO is disrupting the methods in which the Life Sciences companies take their drugs and devices to the Commercial stream with ACTO’s Commercialization Cloud technology.
ACTO uses AI-powered mobile experiences and agency partnerships to educate and engage field reps, physicians and patients, while giving senior commercial and clinical leaders real-time insights.
LinkedIn: https://www.linkedin.com/in/kumar-erramilli-17782834/